Abstract:We show that composite de novo structures can be generated using bio-electrosprays. Mouse lung fibroblasts are bio-electrosprayed directly with a biopolymer to form cell-bearing matrices, which are viable even when implanted subcutaneously into murine hosts. Generated cell-bearing matrices are assessed in-vitro and found to undergo all expected cellular behaviour. Subsequent in-vivo studies demonstrate the implanted living matrices integrating as expected with the surrounding microenvironment. The in-vitro and… Show more
“…A modification to this system has allowed precise placement of bioink in 3D structures. The cell electrospinning method [Figure (d)] involves formation of constructs with cell‐laden fibers in a random or pre‐organized orientation …”
Section: D Bioprinting Techniquesmentioning
confidence: 99%
“…Bioinks utilized in the 3D bioprinting of tissues and organs usually have cells encapsulated in hydrogel solution such as alginate . Synthetic polymers, such as Polydimethylsiloxane (PDMS) and biodegradable polyurethane (PU), are used for improving the mechanical strength of the construct . The use of hydrogels or other materials to encapsulate cells attempts to mimic the role of ECM in the native tissue.…”
The purpose of 3D bioprinting technology is to design and create functional 3D tissues or organs in situ for in vivo applications. 3D cell-printing, or additive biomanufacturing, allows the selection of biomaterials and cells (bioink), and the fabrication of cell-laden structures in high resolution. 3D cell-printed structures have also been used for applications such as research models, drug delivery and discovery, and toxicology. Recently, numerous attempts have been made to fabricate tissues and organs by using various 3D printing techniques. However, challenges such as vascularization are yet to be solved. This article reviews the most commonly used 3D cell-printing techniques with their advantages and drawbacks. Furthermore, up-to-date achievements of 3D bioprinting in in vivo applications are introduced, and prospects for the future of 3D cell-printing technology are discussed.
“…A modification to this system has allowed precise placement of bioink in 3D structures. The cell electrospinning method [Figure (d)] involves formation of constructs with cell‐laden fibers in a random or pre‐organized orientation …”
Section: D Bioprinting Techniquesmentioning
confidence: 99%
“…Bioinks utilized in the 3D bioprinting of tissues and organs usually have cells encapsulated in hydrogel solution such as alginate . Synthetic polymers, such as Polydimethylsiloxane (PDMS) and biodegradable polyurethane (PU), are used for improving the mechanical strength of the construct . The use of hydrogels or other materials to encapsulate cells attempts to mimic the role of ECM in the native tissue.…”
The purpose of 3D bioprinting technology is to design and create functional 3D tissues or organs in situ for in vivo applications. 3D cell-printing, or additive biomanufacturing, allows the selection of biomaterials and cells (bioink), and the fabrication of cell-laden structures in high resolution. 3D cell-printed structures have also been used for applications such as research models, drug delivery and discovery, and toxicology. Recently, numerous attempts have been made to fabricate tissues and organs by using various 3D printing techniques. However, challenges such as vascularization are yet to be solved. This article reviews the most commonly used 3D cell-printing techniques with their advantages and drawbacks. Furthermore, up-to-date achievements of 3D bioprinting in in vivo applications are introduced, and prospects for the future of 3D cell-printing technology are discussed.
“…Using both BES and cell electrospinning has shown to be a promising strategy for the production of biomaterials with cells homogenously distributed in the entire structure. This emerging concept and methodology of BES is a novel and cutting-edge technique, which provides a diversity of biological applications, such as constructing 3-dimensional cell cultures and matrices, fully functional microenvironments and cultures as model systems used for understanding pathology, high throughput screening studies in drug discovery and development, 163,164 or for bioanalysis and medical diagnostics. 165 Moreover, synthetic tailormade tissues and organs or controlled and targeted delivery of cell therapies to specific cellular organs which could enable the delivery of personalized medicine and treatment to particular patients with a given disease state can be regarded as an application area of BES.…”
Section: Bioelectrospraying and Cell Electrospinningmentioning
The electrohydrodynamic atomization technique, or simply called electrospraying, has been extensively studied for biomedical as well as for pharmaceutical applications over the past years. The simplicity, flexibility, and efficiency of producing particles at the microscale or nanoscale, with tailored size, shape, morphology, and microstructure, make electrospraying to become one of the most promising and well-practiced approaches to be applied in many biomedical and pharmaceutical fields, from improving the bioavailability of poorly aqueous soluble drugs, preparing targeted drug delivery systems, and controllable drug release systems to delivering sensitive therapeutic agents such as protein-based drugs or even living cells. Nevertheless, some issues still remain with respect to low throughput as well as the complex interplay between a great number of processing and formulation factors. A comprehensive understanding of these fundamental aspects is essential for the successful application of electrospraying for the production of particulate formulations with desired properties.
“…Some efforts have involved fabrication of electrospun cell bearing matrices, which has largely been evaluated in a review by Jayasinghe [75]. Although key challenge is ensuring cells survive the electrospinning process, bacteria have successfully been electrospun [76] and cell-bearing fiber matrices have successfully been tested in mouse models [77].…”
Electrospinning is a simple, low-cost and versatile approach to fabricate multifunctional materials useful in drug delivery and tissue engineering applications. Despite its emergence into other manufacturing sectors, electrospinning has not yet made a transformative impact in the clinic with a pharmaceutical product for use in humans. Why is this the current state of electrospun materials in biomedicine? Is it because electrospun materials are not yet capable of overcoming the biological safety and efficacy challenges needed in pharmaceutical products? Or, is it that technological advances in the electrospinning process are needed? This review investigates the current state of electrospun materials in medicine to identify both scientific and technological gaps that may limit clinical translation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.